Evidence map›Paper›PMID 38929916›Full record

ArticleJournal of clinical medicine2024

Distinguishing Axillary Lymphadenopathy after COVID-19 Vaccination from Malignant Lymphadenopathy.

Shintaro Yamanaka, Keiko Tanaka, Masao Miyagawa, Teruhito Kido, Shinji Hasebe, Shoichiro Yamamoto, Tomomi Fujii, Kazuto Takeuchi, Yoshihiro Yakushijin

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shintaro YamanakaDepartment of Clinical Oncology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan.ORCID 0009-0001-9988-5413
Keiko TanakaDepartment of Epidemiology and Public Health, Ehime University Graduate School of Medicine, Toon 791-0295, Japan.
Masao MiyagawaDepartment of Radiology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan.
Teruhito KidoDepartment of Radiology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan.
Shinji HasebeDepartment of Clinical Oncology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan.
Shoichiro YamamotoDepartment of Clinical Oncology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan.
Tomomi FujiiDepartment of Clinical Oncology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan.
Kazuto TakeuchiDepartment of Clinical Laboratory, Ehime Prefectural University of Health Sciences, Tobe 791-2101, Japan.
Yoshihiro YakushijinDepartment of Clinical Oncology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan.ORCID 0000-0001-6001-746X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

18F-FDG PETaxillary-lymphadenopathyCOVID-19vaccine

Identifiers

PMID38929916
PMCPMC11205010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.